|
All Clinical trials
Citations 531-540 of 604 total displayed.
|
Past content
(since Jan 2000):
|
- ARTICLES
Assessment of low-flow CSF drainage as a treatment for AD: Results of a randomized pilot study
- G. D. Silverberg, E. Levinthal, E. V. Sullivan, D. A. Bloch, S. D. Chang, J. Leverenz, S. Flitman, R. Winn, F. Marciano, T. Saul, S. Huhn, M. Mayo, and D. McGuire
Neurology 2002; 59: 1139-1145.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Enhancement of use-dependent plasticity by D-amphetamine
- L. Sawaki, L. G. Cohen, J. Classen, B. C. Davis, and C. M. Bütefisch
Neurology 2002; 59: 1262-1264.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Treatment options for central neurocytoma
- Dirk Rades and Fabian Fehlauer
Neurology 2002; 59: 1268-1270.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS
- Scott S. Zamvil and Lawrence Steinman
Neurology 2002; 59: 970-971.
[Full text]
[PDF]
- ARTICLES
Statins as immunomodulators: Comparison with interferon-ß1b in MS
- O. Neuhaus, S. Strasser-Fuchs, F. Fazekas, B.C. Kieseier, G. Niederwieser, H.P. Hartung, and J.J. Archelos
Neurology 2002; 59: 990-997.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group
- CHAMPS Study Group
Neurology 2002; 59: 998-1005.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
- S. N. Raja, J. A. Haythornthwaite, M. Pappagallo, M. R. Clark, T. G. Travison, S. Sabeen, R. M. Royall, and M. B. Max
Neurology 2002; 59: 1015-1021.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange
- Yang Mao-Draayer, Steven Braff, William Pendlebury, and Hillel Panitch
Neurology 2002; 59: 1074-1077.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator
- Andrei V. Alexandrov and James C. Grotta
Neurology 2002; 59: 862-867.
[Abstract]
[Full text]
[PDF]
- HISTORICAL NEUROLOGY
Denny–Brown, Wilson’s disease, and BAL (British antilewisite [2,3-dimercaptopropanol])
- Joel A. Vilensky, Wendy M. Robertson, and Sid Gilman
Neurology 2002; 59: 914-916.
[Abstract]
[Full text]
[PDF]
|
|
